WeightWatchers is going all-in on trendy new anti-obesity drugs. The gamble might save the company—if it doesn’t kill it first. By Emma Court and Ellen Huet

<p>WeightWatchers is going all-in on trendy new anti-obesity drugs. The gamble might save the company—if it doesn’t kill it first. By Emma Court and Ellen Huet</p>

Our editors bring you the most interesting reporting from this week in the world of business, finance, tech, and politics.

Listen to the Story

How Many Points Is a Shot of Wegovy?

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/4415699e-af13-4e45-a762-b043018509a3/transcript

Advertisement